glp 1 approved for What to know about the new era of GLP-1 drugs GLP-1/GIP Receptor Agonists and Diabetic

J Diabetes Res (2020) 2020:1652403

This has empowered patients to ask their doctors about these medications specifically, further driving up prescription rates

The drug completed three Phase III clinical trials before approval, with results published in The Lancet Diabetes & Endocrinology

Based on the strength of the clinical data, we expect Wegovy to be added to formularies with utilization management restrictions for prior authorization to prevent off-label use, shorter initial approval periods (e.g., six months approved initially) to ensure efficacy, and quantity limits to reduce stockpiling and waste

The idea is to use the hormone-mimicking effects of semaglutide alongside the appetite-suppressing stimulant effects of phentermine